Equibles does not estimate personal net worth.
Get an email with a short summary when Sionna Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get SION alertsMichael Cloonan is recorded as CEO at Sionna Therapeutics, Inc. (SION). The proxy statement of Sionna Therapeutics, Inc. reports total compensation of $6,981,217 for Michael Cloonan in fiscal 2025, including a base salary of $646,580. Disclosed compensation is on record for 3 fiscal years. Michael Cloonan has spoken on 2 investor events across 1 company, most recently for Sionna Therapeutics, Inc. on November 9, 2026. Sionna Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Sionna Therapeutics, Inc. includes Elena Ridloff (CFO), H. Edward Fleming (Board Member), Joanne Louise Viney (Board Member) and 2 others.
“Well, first, Yatan, thank you for inviting us as always. Great to be here with you and with Guggenheim, and great to see everybody in the room. So I'm Mike Lunen, the CEO.”
“And, yeah, so as we think about, you've hit it on the head, we're really focused right now on that summer of 26, as you articulated. We have two different data readouts happening in the summer of 26.”
Biotechnology · Healthcare
CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Sionna Therapeutics, Inc. (SION) | M.B.A. President and Chief Executive Officer | $646,580 | $6,981,217 |
| 2024 | Sionna Therapeutics, Inc. (SION) | M.B.A. Chief Executive Officer | $506,189 | $3,726,785 |
| 2023 | Sionna Therapeutics, Inc. (SION) | M.B.A. Chief Executive Officer | $486,720 | $754,416 |
